All In MedTech

Device Trial Radar · NCT06237348

Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH

Airway Clearance Therapy With Simeox Technology in Non-Cystic Fibrosis Bronchiectasis Patients With Chronic Mucus Hypersecretion - A Multicenter Randomized Controlled Trial Pilot Study

Last checked: Nov 20, 2026Latest source record: Aug 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

50

Actual

Start

Dec 1, 2023

Primary completion

Dec 30, 2024

Study completion Dec 30, 2024

Sponsor

Lead sponsor
Physio-AssistNot on our public-company list
Sponsor type
Industry
Collaborators
Medical University of Lodz; University Hospital in Krakow
First posted
Feb 1, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This pilot RCT will assess benefits of Simeox technology on lung function, respiratory symptoms, health-related quality of life, subjective efficiency, device adherence at home, Patient satisfaction, tolerance, safety, and telecare feasibility.

Conditions

  • Non-cystic Fibrosis Bronchiectasis
  • Chronic Mucus Hypersecretion

Interventions

  • SimeoxDevice

    Daily airway clearance therapy at home during 2 months

  • ControlCombination product

    Daily airway clearance therapy at home during 2 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To describe the evolution in Self-reported home adherence from baseline (hospital discharge) during follow-upTime frame: 2 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Jagiellonian University Medical College

    Krakow, Poland

  • N. Barlicki University Hospital No 1

    Lodz, Poland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.